Navigation Links
ImmunGene's Interferon Payload Technology Platform Featured in BioCentury Magazine
Date:2/11/2011

telligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.

About ImmunGene, Inc.

ImmunGene is a privately-held, drug discovery and development company, tapping the power of the immune system to develop the next generation of antibody-based therapeutics to treat cancer, autoimmune and infectious diseases. Our technology platform, available for non-exclusive licensing, offers pharma and biotech companies the possibility of utilizing lower doses of their drug candidates for enhanced clinical efficacy, simplifying the manufacturing process, and lowering cost of goods. Our three novel pipeline candidates are antibody-cytokine fusions that have demonstrated targeted efficacy superior to existing therapies in vitro and in vivo testing. For more information please visit www.immungene.com.

This press release contains certain forward-looking statements relating to our business. Actual events or results may differ from the expectations set forth herein as a result of a number of factors, including uncertainties inherent in pre-clinical studies, clinical trials and product development programs. There can be no assurance that any product in ImmunGene's pipeline or technology platform will be successfully developed or manufactured, that final results of clinical studies will be supportive of regulatory approvals required to market licensed products, or that any of the forward-looking information provided herein will be proven accurate.


'/>"/>
SOURCE ImmunGene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Teriflunomide in Adjunct to Interferon Beta Significantly Improved Outcomes of Multiple Sclerosis Patients
2. Web Resource for Interferon Research
3. Anadys Pharmaceuticals Receives FDA Clearance of Phase II Protocol to Study ANA598 in Combination With Interferon-Alpha and Ribavirin in HCV Patients
4. Helix BioPharma Receives Approval to Initiate Phase II Pharmacokinetic Clinical Study of Topical Interferon Alpha-2b in Patients with Low-Grade Cervical Lesions
5. Pinpoint precision: Delivering a biochemical payload to 1 cell
6. Thermal Gradient Announces Breakthrough in Fast PCR Device Technology
7. Cmed Technology to Host Roundtable, Give Presentation About EDC Pain Points at Summit for Clinical Ops Executives (SCOPE)
8. Amgen to Acquire BioVex, a Privately Held Biotechnology Company Headquartered in Woburn, Mass
9. Cellectis Meganuclease Technology Used to Efficiently Prevent Viral Infection
10. Semiconductor technology for ULSIC and TFT conference
11. Reportlinker Adds Industrial Biotechnology China News 1011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... At the request of the AMA, the ... for the public comment period (Docket No. FAA-2014-0396) for ... established by Congress as part of the FAA Modernization ... the new deadline for comments as September 23, 2014. ... published in the Federal Register on July 25, 2014, ...
(Date:7/25/2014)... , July 25, 2014 Sinovac Biotech Ltd. ... products in China , today announced that ... quarter ended June 30, 2014, after market close on Thursday, ... call prior to the market opening on Friday, August 15, ... 8:00 p.m. China Standard Time) to review the Company,s financial ...
(Date:7/24/2014)... July 24, 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the ... randomized, active control Phase 3 study of Zerenex (ferric ... for the treatment of hyperphosphatemia in patients with end-stage ... binding and iRon delivery with FErric CiTrate in EsrD) ... the American Society of Nephrology ( JASN ). ...
(Date:7/24/2014)... RIDGE, Tenn., July 24, 2014 -- A novel combination ... the Department of Energy,s Oak Ridge National Laboratory an ... for its unusual physical and electrochemical properties. , ... how oxygen affects the surface of a perovskite manganite, ... behavior. The new avenue to understand surface behavior could ...
Breaking Biology Technology:FAA Grants Comment Extension at the Request of AMA 2Sinovac to Host Conference Call to Report Second Quarter 2014 Unaudited Financial Results 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4ORNL study reveals new characteristics of complex oxide surfaces 2
... , June 25 Ruedi Waeger , Ph.D., former president ... of Directors, was honored with the Robert W. Reilly Leadership award June ... , , , ... Plasma Protein Therapeutics Association (PPTA) and recognizes individuals who exemplify the leadership qualities ...
... Beardsworth Consulting Group, Inc. announces the appointments of ... Robert W. Malone , M.D. as the company,s Medical Director, Vaccines. ... Dr. Alison Martin ... of clinical research experience.  She joins Beardsworth from the National Cancer Institute ...
... HOPKINTON, Mass. , June 25 Caliper Life ... and services for drug discovery and life sciences research, hosted its ... 9 and 10. This thought-leadership conference is focused on sharing ... process, leading to the next generation of breakthrough diagnostics and therapies. ...
Cached Biology Technology:Ruedi Waeger Receives the 2010 Robert W. Reilly Leadership Award from Plasma Protein Therapeutics Association 2Alison Martin, MD and Robert W. Malone, MD Join Beardsworth 2Caliper Owners Group Meeting Showcases Critical Role of Biopharma and Academic Researchers for Improving Healthcare and Quality of Life 2Caliper Owners Group Meeting Showcases Critical Role of Biopharma and Academic Researchers for Improving Healthcare and Quality of Life 3
(Date:7/24/2014)... a low vision specialist at The University of Texas ... been awarded a grant to help Harris County residents ... or surgery. , Even with corrective lenses, many people ... there are a variety of low vision devices, such ... their vision loss. , Iyer is using the three-year, ...
(Date:7/24/2014)... week for an all-day public forum on a $1.7 ... to dredge toxic sediment from an eight-mile stretch of ... the plan, which proposes removing 4.3 million cubic yards ... one of the largest cleanups in the agency,s history. ... , "We need to ensure the future well-being of ...
(Date:7/24/2014)... the United States, wildland managers often utilize the silvicultural ... (ladder fuels). These cuttings and other post-logging debris ... in order to dispose of the material. To improve ... cover all or part of the debris pile with ... in order to keep water out. A recent study ...
Breaking Biology News(10 mins):UTHealth Dr. Bhavani Iyer awarded low vision grant 2Experts Weigh the Pros and Cons of a $1.7 Billion EPA Cleanup Plan for the Passaic River at an NJIT 2Study gives new perspective on agricultural plastic, debris burning, and air quality 2
... of Energy,s Advanced Research Projects Agency (ARPA-E) has awarded ... Carolina State University to support research into the creation ... in high-temperature environments. "Most biofuels, such as ethanol ... plants through photosynthesis. Our project would cut out the ...
... A system that allows precise targeting of radiotherapy using ... dose of radiation they administered to lung and liver cancers ... the 2nd European Lung Cancer Conference. "With this study ... have a precise system that can give information at any ...
... is available in Spanish . , Agricultural ... Research Center in Burns, Ore., are taking a careful ... high desert rangelands. Cattle share this habitat with ... the showy commotion they create during mating season. But ...
Cached Biology News:NC State wins ARPA-E grant to study extremophile production of biofuels 2ARS scientists study effects of grazing on grouse habitat 2
AedestaTM Animal Organ/Tissue Perfusion Soln....
ANTI FLAG EP CL VEC...
Cross reactivity to St. Louis encephalitis (MSI-7) is determined by ELISA....
EGTA, 10 g. Ethylene glycol-O,O-bis-[2-amino-ethyl]-N,N,N,N,-tetraacetic acid.Assay: > 99.0%. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Biology Products: